Document is current
Any future updates will be listed below
-
Authors
Kamei, Koichi https://orcid.org/0000-0003-3528-6961
Miyairi, Isao
Shoji, Kensuke
Arai, Katsuhiro
Kawai, Toshinao
Ogura, Masao
Ishikura, Kenji
Sako, Mayumi
Nakamura, Hidefumi
-
Funding
Funding for this research was provided by:
grants from the National Center for Child Health and Development (30-7)
the Japan Foundation for Pediatric Research (17-004)
- License Information
-
More Information
Article History
Received: 27 July 2020
Revised: 16 November 2020
Accepted: 1 January 2021
First Online: 1 February 2021
Declaration
:
: All procedures performed in this study were in accordance with the principles of the 1964 Helsinki Declaration and the ethical guidelines issued by the Ministry of Health, Labour and Welfare in Japan. The questionnaires and methodology for this study were approved by the ethics committee of the National Center for Child Health and Development (approval number: 1567).
: Because of this kind of study, informed consent was waived in accordance with the guidelines.
: Koichi Kamei received grants from the Terumo Foundation for Life Sciences and Arts, Chugai Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., and Pfizer Japan, Inc. and lecture fees from Tanabe Mitsubishi Pharma, Novartis Pharma K.K., Chugai Pharmaceutical Co. Ltd., and AbbVie Inc. Isao Miyairi received lecture fees from Fuji Film Toyama Pharmaceutical Co., Ltd., Teijin Pharm, Meiji Seika Pharma Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical Co. Ltd., Astellas, bioMérieux Japan Ltd., Sanofi, Japan vaccine, Abbie GK, and Abbot. Kensuke Shoji received lecture fees from Taisho Toyama Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Shionogi & Co., Ltd., Sumitomo Dainippon Pharma, Mitsubishi Tanabe Pharma, Astellas, bioMérieux Japan Ltd., and Abbie GK. Kenji Ishikura has received grants from Asahi Kasei Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Novartis International AG, Zenyaku Kogyo Co., Ltd., Japan Blood Products Organization, Otsuka pharmaceutical Co. ltd., Teijin Pharma Limited, Shionogi Co., Ltd., Eisai Co., Ltd., and JCR Pharmaceuticals Co., Ltd. and lecture fees from Asahi Kasei Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Novartis International AG, Zenyaku Kogyo Co. Ltd., Otsuka pharmaceutical Co. Ltd., and Pfizer Inc.
